Developer of brain disorder medicines. The company provides research and development services for cyclin-dependent kinase-like 5 focused on treatment of brain disorders.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore MiaMed‘s full profile, request access.
Request a free trialName | Title | Board Seat | Contact Info |
---|---|---|---|
Michael Jasulavic | Chief Executive Officer & President |